Paradox Immunotherapeutics Analysis: $10M Raised
What is Paradox Immunotherapeutics?
Monoclonal antibody treatment for protein misfolding diseases
Location
Toronto, Canada
Employees
1-10
Founded
2019
Product Features & Capabilities
- LX-96
- KX-99
- NX-86
Other Considerations
Three pre-clinical stage antibodies with commercial interest; Team includes experts in monoclonal development and protein biochemistry; Addresses a global healthcare crisis affecting 300 people per million worldwide
